Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study

Introduction For people with type 2 diabetes mellitus (T2DM) who require an antidiabetic drug as an add-on to metformin, there is controversy about whether newer drug classes such as dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co-transporter-2 inhibitors (SGLT2i) reduce the risk of l...

Full description

Bibliographic Details
Main Authors: Bidulka, P, O'Neill, S, Basu, A, Wilkinson, S, Silverwood, RJ, Charlton, P, Briggs, A, Adler, AI, Khunti, K, Tomlinson, LA, Smeeth, L, Douglas, IJ, Grieve, R
Format: Journal article
Language:English
Published: BMJ Publishing Group 2021

Similar Items